{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:56:09Z","timestamp":1764842169328,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41390-019-0319-6","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T07:03:10Z","timestamp":1548831790000},"page":"931-933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluating anti-epileptic drugs in the era of therapeutic hypothermia"],"prefix":"10.1038","volume":"85","author":[{"given":"Joanne O.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bennet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-7035","authenticated-orcid":false,"given":"Alistair J.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"319_CR1","doi-asserted-by":"publisher","unstructured":"Soul, J. et al. Recommendations for the design of therapeutic trials for neonatal seizures. Paediatr Res. (2018). \n                     https:\/\/doi.org\/10.1038\/s41390-018-0242-2\n                    \n                  .","DOI":"10.1038\/s41390-018-0242-2"},{"key":"319_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1212\/WNL.0000000000004284","volume":"89","author":"RA Shellhaas","year":"2017","unstructured":"Shellhaas, R. A. et al. Profile of neonatal epilepsies: characteristics of a prospective US cohort. Neurology 89, 893\u2013899 (2017).","journal-title":"Neurology"},{"key":"319_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.siny.2013.02.003","volume":"18","author":"R Nardou","year":"2013","unstructured":"Nardou, R., Ferrari, D. C. & Ben-Ari, Y. Mechanisms and effects of seizures in the immature brain. Semin. Fetal Neonatal Med. 18, 175\u2013184 (2013).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"319_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.clp.2009.08.001","volume":"36","author":"FE Jensen","year":"2009","unstructured":"Jensen, F. E. Neonatal seizures: an update on mechanisms and management. Clin. Perinatol. 36, 881\u2013900 (2009). vii.","journal-title":"Clin. Perinatol."},{"key":"319_CR5","first-page":"362","volume":"9","author":"C Zhou","year":"2015","unstructured":"Zhou, C., Sun, H., Klein, P. M. & Jensen, F. E. Neonatal seizures alter NMDA glutamate receptor GluN2A and 3A subunit expression and function in hippocampal CA1 neurons. Front. Cell. Neurosci. 9, 362 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"319_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pediatrneurol.2017.04.016","volume":"72","author":"HC Glass","year":"2017","unstructured":"Glass, H. C. et al. Seizures in preterm neonates: a multicenter observational cohort study. Pediatr. Neurol. 72, 19\u201324 (2017).","journal-title":"Pediatr. Neurol."},{"key":"319_CR7","doi-asserted-by":"publisher","unstructured":"Evans, D. J., Levene, M. I. & Tsakmakis, M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst. Rev. 2007. Art. No.: CD001240. \n                     https:\/\/doi.org\/10.1002\/14651858.CD001240.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD001240.pub2"},{"key":"319_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12640-018-9872-8","volume":"34","author":"S Endesfelder","year":"2018","unstructured":"Endesfelder, S. et al. Caffeine protects against anticonvulsant-induced impaired neurogenesis in the developing rat brain. Neurotox. Res. 34, 173\u2013187 (2018).","journal-title":"Neurotox. Res."},{"key":"319_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/000992289903800702","volume":"38","author":"S Sulzbacher","year":"1999","unstructured":"Sulzbacher, S., Farwell, J. R., Temkin, N., Lu, A. S. & Hirtz, D. G. Late cognitive effects of early treatment with phenobarbital. Clin. Pediatr. (Phila.) 38, 387\u2013394 (1999).","journal-title":"Clin. Pediatr. (Phila.)"},{"key":"319_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41372-018-0126-7","volume":"38","author":"G Natarajan","year":"2018","unstructured":"Natarajan, G. et al. Association between sedation-analgesia and neurodevelopment outcomes in neonatal hypoxic-ischemic encephalopathy. J. Perinatol. 38, 1060\u20131067 (2018).","journal-title":"J. Perinatol."},{"key":"319_CR11","doi-asserted-by":"publisher","first-page":"F267","DOI":"10.1136\/archdischild-2011-300716","volume":"97","author":"E Low","year":"2012","unstructured":"Low, E. et al. Cooling and seizure burden in term neonates: an observational study. Arch. Dis. Child. Fetal Neonatal Ed. 97, F267\u2013F272 (2012).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"319_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00381-016-3321-x","volume":"33","author":"S Ghosh","year":"2017","unstructured":"Ghosh, S., Tran, L., Shuster, J. J. & Zupanc, M. L. Therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy is associated with short-term reduction of seizures after discharge from the neonatal intensive care unit. Childs Nerv. Syst. 33, 329\u2013335 (2017).","journal-title":"Childs Nerv. Syst."},{"key":"319_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1177\/0883073811408092","volume":"26","author":"MJ Harbert","year":"2011","unstructured":"Harbert, M. J. et al. Hypothermia is correlated with seizure absence in perinatal stroke. J. Child Neurol. 26, 1126\u20131130 (2011).","journal-title":"J. Child Neurol."},{"key":"319_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnins.2014.00040","volume":"8","author":"G Wassink","year":"2014","unstructured":"Wassink, G., Gunn, E. R., Drury, P. P., Bennet, L. & Gunn, A. J. The mechanisms and treatment of asphyxial encephalopathy. Front. Neurosci. 8, 40 (2014).","journal-title":"Front. Neurosci."},{"key":"319_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1203\/PDR.0b013e3181d4ff4d","volume":"67","author":"JD Barks","year":"2010","unstructured":"Barks, J. D., Liu, Y. Q., Shangguan, Y. & Silverstein, F. S. Phenobarbital augments hypothermic neuroprotection. Pediatr. Res. 67, 532\u2013537 (2010).","journal-title":"Pediatr. Res."},{"key":"319_CR16","doi-asserted-by":"crossref","unstructured":"Liu, Y., Shangguan, Y., Barks, J. D. & Silverstein, F. S. Bumetanide augments the neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia\u2013ischemia model. Pediatr. Res. 71, 559\u2013565 (2012).","DOI":"10.1038\/pr.2012.7"},{"key":"319_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/pr.2017.266","volume":"83","author":"S Krishna","year":"2018","unstructured":"Krishna, S., Hutton, A., Aronowitz, E., Moore, H. & Vannucci, S. J. The effects of adding prophylactic phenobarbital to therapeutic hypothermia in the term-equivalent hypoxic\u2013ischemic rat. Pediatr. Res. 83, 506\u2013513 (2018).","journal-title":"Pediatr. Res."},{"key":"319_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","volume":"14","author":"RM Pressler","year":"2015","unstructured":"Pressler, R. M. et al. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial. Lancet Neurol. 14, 469\u2013477 (2015).","journal-title":"Lancet Neurol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0319-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0319-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0319-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:25:32Z","timestamp":1684617932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0319-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0319-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"type":"print","value":"0031-3998"},{"type":"electronic","value":"1530-0447"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"2 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}